Saturday, April 15, 2017

Health Care Tips: A New Combination Therapy Can Improve Surviaval Rate in Brain Cancer

The vaccine targeting CMV antigen pp65, combined with temozolomide, improved both progression-free survival and overall survival for a small group of GBM patients.
Read more: A New Combination Therapy Can Improve Surviaval Rate in Brain Cancer